HDV vs VHT
iShares Core High Dividend ETF vs Vanguard Health Care ETF
- • HDV has the lower expense ratio at 0.08% vs 0.09% for VHT.
- • HDV pays a higher dividend yield (2.90%).
Side-by-side metrics
| Metric | HDV | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.08% | 0.09% |
Dividend yield Trailing 12-month yield. | 2.90% | 1.58% |
AUM Assets under management — bigger funds are typically more liquid. | $13.66B | $20.39B |
YTD return | 16.00% | 7.21% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.32 | 0.57 |
P/E ratio | 21.95 | 26.41 |
Last price | $27.62 | $305.90 |
Inception | — | — |
Issuer | iShares | Vanguard |
HDV top holdings
| XOM | Exxon Mobil Corp | 7.26% |
| ABBV | AbbVie Inc | 6.48% |
| CVX | Chevron Corp | 5.41% |
| VZ | Verizon Communications Inc | 5.23% |
| HD | The Home Depot Inc | 4.96% |
| PG | Procter & Gamble Co | 4.81% |
| PM | Philip Morris International Inc | 4.42% |
| PFE | Pfizer Inc | 4.31% |
| MRK | Merck & Co Inc | 4.12% |
| KO | Coca-Cola Co | 3.98% |
VHT top holdings
| LLY | Eli Lilly and Co | 13.99% |
| JNJ | Johnson & Johnson | 8.44% |
| ABBV | AbbVie Inc | 6.07% |
| UNH | UnitedHealth Group Inc | 5.44% |
| MRK | Merck & Co Inc | 4.63% |
| TMO | Thermo Fisher Scientific Inc | 2.88% |
| AMGN | Amgen Inc | 2.86% |
| GILD | Gilead Sciences Inc | 2.63% |
| ISRG | Intuitive Surgical Inc | 2.38% |
| ABT | Abbott Laboratories | 2.35% |
About HDV
HDV (iShares Core High Dividend ETF) is US high-dividend stocks with quality screen. Managed by iShares, the fund carries $13.7B in assets under management, an expense ratio of 0.08%, a dividend yield of 2.90%. Its largest holding is Exxon Mobil Corp (XOM), which represents 7.3% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 9.3%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $20.4B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.58%. Its largest holding is Eli Lilly and Co (LLY), which represents 14.0% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.